Author: OurCrowd

[EquipmentShare in BusinessWire] MidOcean Partners leads $197.5 million structured equity investment in sale-leaseback transaction with EquipmentShare

NEW YORK–(BUSINESS WIRE)–MidOcean Partners (“MidOcean”), a premier alternative asset manager specializing in middle-market private equity, alternative credit, and structured capital, announced today that it led a $197.5 million structured equity investment in OWN Equipment Fund I LLC, a newly formed special-purpose vehicle. Read...

Read More

[Alloy Therapeutics in BusinessWire] Alloy Therapeutics announces new licensing model for ATX-Gx™ antibody discovery platform and launches mAbForge™ high-throughput screening service

BOSTON–(BUSINESS WIRE)–Alloy Therapeutics (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, announced today that it is launching a new market-disrupting licensing structure. Partners can now have the option to use the ATX-Gx™ antibody technology platform with no annual access fee or development milestones. Partners benefit from Alloy as an ever-growing source of pre-competitive, foundational discovery technology. Read...

Read More

[MeMed in Business Wire] MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR

ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)–MeMed, a leader in host-response diagnostics, today announced the addition of three distinguished experts to its advisory board to accelerate its mission of addressing the global challenges of sepsis and antimicrobial resistance (AMR) through innovative diagnostic solutions. Read more...

Read More